CXCR4 antagonist-loaded nanoparticles reprogram the tumor microenvironment and enhance immunotherapy in hepatocellular carcinoma.
Cheng SL, Wu CH, Tsai YJ, Song JS, Chen HM, Yeh TK, Shen CT, Chiang JC, Lee HM, Huang KW, Chen Y, Qiu JT, Yen YT, Shia KS, Chen Y.
Cheng SL, et al. Among authors: wu ch.
J Control Release. 2025 Jan 23:S0168-3659(25)00076-8. doi: 10.1016/j.jconrel.2025.01.066. Online ahead of print.
J Control Release. 2025.
PMID: 39863023